Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 150 of 984 entries
View as:

Specified Drug-Use Survey on Vedolizumab for IV Infusion 300 mg [Ulcerative Colitis]

Phase: N/A Priority: Normal
NCT ID: NCT03824561 Org: User:
Start: 02/01/19 End: 02/12/25 Due: 02/12/26

TAK-329 Glucose Clamp Study

Phase: N/A Priority: Normal
NCT ID: NCT01311076 Org: User:
Start: 03/31/11 End: 01/31/12 Due: 01/31/13

Efficacy of Candesartan on Brain Natriuretic Peptide Levels in Subjects With Chronic Heart Failure

Phase: N/A Priority: Normal
NCT ID: NCT00843154 Org: User:
Start: 12/31/05 End: 07/31/08 Due: 07/31/09

A Study of TAK-881 in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT05059977 Org: User:
Start: 10/12/21 End: 04/12/22 Due: 04/12/23

A Study of TAK-360 in Adults With Narcolepsy Without Cataplexy (NT2)

Phase: N/A Priority: Normal
NCT ID: NCT06952699 Org: User:
Start: 05/06/25 End: 04/23/26 Due: 04/23/27

Efficacy of TAK-559 in Treating Subjects With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT00763022 Org: User:
Start: 11/30/03 End: 12/31/04 Due: 12/31/05

Efficacy and Safety of Azilsartan Medoxomil and Chlorthalidone in Participants With Moderate to Severe Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00818883 Org: User:
Start: 02/28/09 End: 11/30/09 Due: 11/30/10

Survey of Cabozantinib Tablets Used To Treat People With Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT05100082 Org: User:
Start: 11/17/21 End: 11/30/25 Due: 11/30/26

A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

Phase: N/A Priority: Normal
NCT ID: NCT06747351 Org: User:
Start: 05/06/25 End: 06/25/28 Due: 06/25/29

AD-4833/TOMM40_303 Extension Study of the Safety and Efficacy of Pioglitazone to Slow Cognitive Decline in Participants With Mild Cognitive Impairment Due to Alzheimer Disease

Phase: N/A Priority: Normal
NCT ID: NCT02284906 Org: User:
Start: 02/12/15 End: 05/08/18 Due: 05/08/19

Safety and Efficacy of Dexlansoprazole Modified Release Formulation to Treat Gastroesophageal Reflux Disease

Phase: N/A Priority: Normal
NCT ID: NCT00321984 Org: User:
Start: 06/30/06 End: 12/31/06 Due: 12/31/07

A Study to Learn About Brigatinib Treatment Information Available in Chinese Participants With Non-Small-cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT05721950 Org: User:
Start: 01/17/24 End: 12/30/28 Due: 12/30/29

TAK-071 Scopolamine-Induced Cognitive Impairment Study

Phase: N/A Priority: Normal
NCT ID: NCT02918266 Org: User:
Start: 11/21/16 End: 08/08/17 Due: 08/08/18

A Safety and Tolerability Study of Peginesatide in Anemic Cancer Patients Receiving Cytotoxic Chemotherapy.

Phase: N/A Priority: Normal
NCT ID: NCT00629876 Org: User:
Start: 01/31/08 End: 06/30/08 Due: 06/30/09

A Bioequivalence Study of the Lu AA21004 20 mg and 2×10 mg Tablets

Phase: N/A Priority: Normal
NCT ID: NCT03437564 Org: User:
Start: 02/16/18 End: 04/13/18 Due: 04/13/19

A Survey of Susoctocog Alfa (Genetical Recombination) in Participants With Acquired Haemophilia A

Phase: N/A Priority: Normal
NCT ID: NCT06461533 Org: User:
Start: 06/10/24 End: 10/31/29 Due: 10/31/30

A Study of the Interaction of TAK-279 With Substances That Have an Impact on Metabolism in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT05995249 Org: User:
Start: 08/11/23 End: 12/31/23 Due: 12/31/24

Long-term Safety With Vedolizumab Intravenous (IV) in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD)

Phase: N/A Priority: Normal
NCT ID: NCT03196427 Org: User:
Start: 07/30/18 End: 08/07/25 Due: 08/07/26

Specified Drug-use Survey of the Granular Capsule Formulation of Omega-3 Fatty Acid Ethyl Esters: OCEAN3

Phase: N/A Priority: Normal
NCT ID: NCT02285166 Org: User:
Start: 10/21/14 End: 07/14/20 Due: 07/14/21

Japan Phase 2 Study of Niraparib (Maintenance Therapy) in Participants With Relapsed Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03759587 Org: User:
Start: 12/28/18 End: 12/28/22 Due: 12/28/23

Use of Tachosil® for Lymph Sealing During Surgery

Phase: N/A Priority: Normal
NCT ID: NCT01920958 Org: User:
Start: 09/30/12 End: 03/31/14 Due: 03/31/15

A Study of Oral Ixazomib Citrate (MLN9708) Maintenance Therapy in Participants With Multiple Myeloma Following Autologous Stem Cell Transplant

Phase: N/A Priority: Normal
NCT ID: NCT02181413 Org: User:
Start: 07/16/14 End: 09/08/23 Due: 09/08/24

Efficacy and Safety of Alogliptin Plus Metformin in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01023581 Org: User:
Start: 11/30/09 End: 06/30/11 Due: 06/30/12

Efficacy and Safety of TAK-438 for the Prevention of Recurrent Gastric or Duodenal Ulcers During Therapy of Low-dose Aspirin

Phase: N/A Priority: Normal
NCT ID: NCT01452763 Org: User:
Start: 10/31/11 End: 04/30/13 Due: 04/30/14

Drug-Drug Interaction Study Between TAK-272 and Itraconazole, Digoxin or Midazolam

Phase: N/A Priority: Normal
NCT ID: NCT02370615 Org: User:
Start: 02/28/15 End: 04/30/15 Due: 04/30/16